Table 3.
Change in expression of chemokine receptors in peripheral monocytes after 13-week treatment
| Monocyte population | Percentage of relative fluorescence intensity | Number of patients with a positive response | P | Percentage of positive cells | Number of patients with a positive response | P |
|---|---|---|---|---|---|---|
| CCR2 | ||||||
| CD14highCD16− | −25 | 9/10 | 0.020 | −34 | 7/10 | 0.064 |
| CD14highCD16+ | −12 | 9/10 | 0.049 | −23 | 9/10 | 0.064 |
| CX3CR1 | ||||||
| CD14highCD16− | −20 | 7/10 | 0.105 | −31 | 8/10 | 0.049 |
| CD14highCD16+ | −29 | 8/10 | 0.049 | −24 | 9/10 | 0.014 |
| CD14lowCD16+ | −19 | 7/10 | 0.275 | −5 | 7/10 | 0.131 |
| CD14+CD56+ | −21 | 8/10 | 0.084 | −40 | 8/10 | 0.064 |